Ronen Brenner

1.8k total citations
37 papers, 568 citations indexed

About

Ronen Brenner is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Ronen Brenner has authored 37 papers receiving a total of 568 indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Oncology, 12 papers in Pulmonary and Respiratory Medicine and 7 papers in Molecular Biology. Recurrent topics in Ronen Brenner's work include Lung Cancer Treatments and Mutations (8 papers), Colorectal Cancer Treatments and Studies (7 papers) and Colorectal Cancer Surgical Treatments (6 papers). Ronen Brenner is often cited by papers focused on Lung Cancer Treatments and Mutations (8 papers), Colorectal Cancer Treatments and Studies (7 papers) and Colorectal Cancer Surgical Treatments (6 papers). Ronen Brenner collaborates with scholars based in Israel, United States and France. Ronen Brenner's co-authors include Nir Peled, Gisele Zandman‐Goddard, Milena Tocut, Murry W. Wynes, Maya Ilouze, Dekel Shlomi, Shaye Kivity, Carmit Levy, Baruch Brenner and Yulia Kundel and has published in prestigious journals such as Journal of Clinical Investigation, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Ronen Brenner

30 papers receiving 561 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ronen Brenner Israel 10 286 213 165 137 90 37 568
Tianshu Liu China 16 348 1.2× 263 1.2× 211 1.3× 156 1.1× 104 1.2× 91 809
Yu Fujiwara United States 13 300 1.0× 106 0.5× 99 0.6× 49 0.4× 72 0.8× 57 535
Hironori Ishida Japan 14 257 0.9× 211 1.0× 222 1.3× 64 0.5× 213 2.4× 55 716
Jiannan Yao China 14 237 0.8× 84 0.4× 188 1.1× 106 0.8× 110 1.2× 45 553
Elizabeth K. Lee United States 13 309 1.1× 153 0.7× 205 1.2× 59 0.4× 55 0.6× 34 662
Glauce Aparecida Pinto Brazil 12 313 1.1× 70 0.3× 132 0.8× 116 0.8× 94 1.0× 40 635
Ana Iulia Neagu Romania 10 113 0.4× 140 0.7× 268 1.6× 199 1.5× 92 1.0× 23 553
Antonino Belfiore Italy 12 157 0.5× 88 0.4× 211 1.3× 156 1.1× 48 0.5× 20 473
Shintaro Kawasaki Japan 8 421 1.5× 90 0.4× 190 1.2× 172 1.3× 159 1.8× 29 676
Sung Sun Kim South Korea 11 110 0.4× 168 0.8× 244 1.5× 101 0.7× 80 0.9× 57 520

Countries citing papers authored by Ronen Brenner

Since Specialization
Citations

This map shows the geographic impact of Ronen Brenner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ronen Brenner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ronen Brenner more than expected).

Fields of papers citing papers by Ronen Brenner

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ronen Brenner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ronen Brenner. The network helps show where Ronen Brenner may publish in the future.

Co-authorship network of co-authors of Ronen Brenner

This figure shows the co-authorship network connecting the top 25 collaborators of Ronen Brenner. A scholar is included among the top collaborators of Ronen Brenner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ronen Brenner. Ronen Brenner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yakobson, Alexander, et al.. (2025). Exploring the Impact of TP53 Mutation and Wild-Type Status on the Efficacy of Immunotherapy in Non-Small Cell Lung Cancer. International Journal of Molecular Sciences. 26(14). 6939–6939. 1 indexed citations
2.
3.
Parikh, Shivang, L. Thomas, Roma Parikh, et al.. (2024). Impairing hydrolase transport machinery prevents human melanoma metastasis. Communications Biology. 7(1). 574–574.
4.
Rosenberg‐Katz, Keren, et al.. (2024). Comparative efficacy of combined CTLA-4 and PD-1 blockade vs. PD-1 monotherapy in metastatic melanoma: a real-world study. PubMed. 2(1). 14–14. 3 indexed citations
5.
Brenner, Baruch, Ayala Hubert, Sofia Man, et al.. (2023). Treatments and clinical outcomes in stage II colon cancer (CC) patients (pts) with 12-gene Oncotype DX Colon Recurrence Score assay-guided therapy: Real-world data.. Journal of Clinical Oncology. 41(16_suppl). 3620–3620.
6.
7.
Agbarya, Abed, Tomer Ziv‐Baran, Orna Schwartz, et al.. (2023). Response Rate of the Third and Fourth Doses of the BNT162b2 Vaccine Administered to Cancer Patients Undergoing Active Anti-Neoplastic Treatments. SHILAP Revista de lepidopterología. 11(4). 128–128.
8.
Brenner, Ronen, Yael Shinar, Asaf Shemer, et al.. (2022). Determining the origin of different variants associated with familial mediterranean fever by machine-learning. Scientific Reports. 12(1). 15206–15206. 3 indexed citations
9.
Netanely, Dvir, Roma Parikh, Hananya Vaknine, et al.. (2021). Classification of node-positive melanomas into prognostic subgroups using keratin, immune, and melanogenesis expression patterns. Oncogene. 40(10). 1792–1805. 14 indexed citations
10.
Golan, Tamar, Roma Parikh, Etai Jacob, et al.. (2019). Adipocytes sensitize melanoma cells to environmental TGF-β cues by repressing the expression of miR-211. Science Signaling. 12(591). 23 indexed citations
11.
Wine, Yariv, Haim Gutman, Alexander Tsivian, et al.. (2019). A distinct subset of FcγRI-expressing Th1 cells exert antibody-mediated cytotoxic activity. Journal of Clinical Investigation. 129(10). 4151–4164. 7 indexed citations
12.
Iakobishvili, Zaza, Tal Hasin, Robert Klempfner, et al.. (2019). Association of Bezafibrate Treatment With Reduced Risk of Cancer in Patients With Coronary Artery Disease. Mayo Clinic Proceedings. 94(7). 1171–1179. 7 indexed citations
13.
Tocut, Milena, Ronen Brenner, & Gisele Zandman‐Goddard. (2018). Autoimmune phenomena and disease in cancer patients treated with immune checkpoint inhibitors. Autoimmunity Reviews. 17(6). 610–616. 78 indexed citations
14.
Bitzur, Rafael, Ronen Brenner, Elad Maor, et al.. (2016). Metabolic syndrome, obesity, and the risk of cancer development. European Journal of Internal Medicine. 34. 89–93. 31 indexed citations
15.
Tamir, Sharon Ovnat, Yehudah Roth, Udi Cinamon, et al.. (2015). Laryngeal Side Effects of Tyrosine Kinase Inhibitors. Journal of Voice. 30(5). 606–610. 2 indexed citations
16.
Peled, Nir, Murry W. Wynes, Norihiko Ikeda, et al.. (2013). Insulin-like growth factor-1 receptor (IGF-1R) as a biomarker for resistance to the tyrosine kinase inhibitor gefitinib in non-small cell lung cancer. Cellular Oncology. 36(4). 277–288. 74 indexed citations
17.
Purim, Ofer, Yulia Kundel, Ronen Brenner, et al.. (2012). The combination of docetaxel, cisplatin, and 5-fluorouracil in advanced gastric cancer. Anti-Cancer Drugs. 23(3). 313–320. 6 indexed citations
18.
Eitan, Ram, Hanoch Levavi, Yoav Peled, et al.. (2010). Should simple hysterectomy be added after chemo‐radiation for stage IB2 and bulky IIA cervical carcinoma?. Australian and New Zealand Journal of Obstetrics and Gynaecology. 50(3). 289–293. 1 indexed citations
19.
Kundel, Yulia, Ronen Brenner, Ofer Purim, et al.. (2010). Is Local Excision After Complete Pathological Response to Neoadjuvant Chemoradiation for Rectal Cancer an Acceptable Treatment Option?. Diseases of the Colon & Rectum. 53(12). 1624–1631. 55 indexed citations
20.
Brenner, Baruch, et al.. (2010). Local excision after neoadjuvant chemoradiation for rectal cancer: Is it an acceptable treatment option?. Journal of Clinical Oncology. 28(15_suppl). 3646–3646. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Tianshu Liu Breakdown of academic impact, for papers by Yu Fujiwara Breakdown of academic impact, for papers by Hironori Ishida Breakdown of academic impact, for papers by Jiannan Yao Breakdown of academic impact, for papers by Elizabeth K. Lee Breakdown of academic impact, for papers by Glauce Aparecida Pinto Breakdown of academic impact, for papers by Ana Iulia Neagu Breakdown of academic impact, for papers by Antonino Belfiore Breakdown of academic impact, for papers by Shintaro Kawasaki Breakdown of academic impact, for papers by Sung Sun Kim
Rankless by CCL
2026